-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Bm6MLqCanpkQmM7rPSmczrhe4fZSkc6LvBFjhV8HeVg7wvXooTR8BNW/awae5i+3 uO042H2lu5VGutBMj4CHZA== 0001072922-04-000005.txt : 20040615 0001072922-04-000005.hdr.sgml : 20040615 20040615123055 ACCESSION NUMBER: 0001072922-04-000005 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20040615 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: INDEVUS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000854222 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043047911 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-41015 FILM NUMBER: 04863486 BUSINESS ADDRESS: STREET 1: ONE LEDGEMONT CENTER STREET 2: 99 HAYDEN AVE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 6178618444 MAIL ADDRESS: STREET 1: ONE LEDGEMONT CENTER STREET 2: 99 HAYDEN AVE CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: INTERNEURON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: PERLYSKY DOV CENTRAL INDEX KEY: 0001072922 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: LAIDLAW & CO. STREET 2: 100 PARK AVENUE 28TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2123768831 MAIL ADDRESS: STREET 1: LAIDLAW & CO STREET 2: 100 PARK AVENUE 28TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 SC 13G/A 1 ipic-dov13g3.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.____2_______)* Indevus Pharmaceuticals, Inc. ----------------------------------------------------- (Name of Issuer) Common Stock, $.001 par value ------------------------------------------------------------- (Title of Class of Securities) 454072109 ----------------------------------------------------- (CUSIP Number) June 8, 2004 --------------------------------------------- (Date of Event) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [XX] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 5 pages CUSIP No. 454072109 13G Page 2 of 5 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Dov Perlysky - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- NUMBER OF 5 SOLE VOTING POWER SHARES 1,951,100 BENEFICIALLY -------------------------------------------------------------- OWNED BY 6 SHARED VOTING POWER EACH 341,781 REPORTING -------------------------------------------------------------- PERSON 7 SOLE DISPOSITIVE POWER WITH 1,951,100 -------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER 341,781 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,292,881 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.8% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* IN - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT Page 3 of 5 Pages Item 1. (a) Name of Issuer: Indevus Pharmaceuticals, Inc. (b) Address of Issuer's Principal Executive Offices: One Ledgemont Center 99 Hayden Avenue Lexington, MA 02421 Item 2. (a) Name of Person Filing: This statement is filed on behalf of Dov Perlysky (the "Reporting Party"). (b) Address of Principal Business Office: The Reporting Party's address is 8 Lakeside Drive West, Lawrence, New York 11559. (c) Citizen: The Reporting Party is a citizen of the United States. (d) Title of Class of Securities: Common Stock, $.001 par value ("shares"). (e) CUSIP#: 454072109 Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b), check whether the person filing is a: (a) [ ] Broker or Dealer registered under Section 15 of the Act (b) [ ] Bank as defined in section 3(a)(6) of the Act (c) [ ] Insurance Company as defined in section 3(a)(19) of the Act (d) [ ] Investment Company registered under section 8 of the Investment Company Act of 1940 (e) [ ] An investment adviser in accordance with 240.13d-1 (b)(1)(ii)(E) (f) [ ] An employee benefit Plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F) (g) [ ] A parent holding Company or control person in accordance with 240.13d-1(b)(1)(ii)(G) (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (i) [ ] A church plan that is excluded from definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940. Page 4 of 5 Pages Item 4. Ownership: (a)(b)(c) See 5 - 9 and 11 on the coversheet of this Form for the ownership amounts (1). Item 5. Ownership of Five Percent or Less of a Class: The Reporting Party beneficially owns less than 5% of the Issuer's shares. Item 6. Ownership of More than Five Percent on Behalf of Another Person: Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company: Not applicable. Item 8. Identification and Classification of Members of the Group: Not applicable. __________________________________________________________________________ (1) Filing of this statement shall not be deemed an admission by the Reporting Party that he beneficially owns the securities attributed to his wife for any other purpose. The Reporting Party expressly disclaims beneficial ownership of all securities beneficially held by his wife. Page 5 of 5 pages Item 9. Notice of Dissolution of Group: Not applicable. Item 10. Certification: By signing below, I certify that to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired and are not held for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired and are not held in connection with or as participant in any transaction having such purpose of effect. SIGNATURES After reasonable inquiry and to the best knowledge and belief of the Reporting Person, such person or entity certifies that the information set forth in this statement is true, complete and correct. Dated: June 10, 2004 /s/ Dov Perlysky New York, New York _____________________________ Dov Perlysky -----END PRIVACY-ENHANCED MESSAGE-----